# Full Product Details Contrast Refinement — Private Validation Report

**Status:** Owner approved for manual publication on September 22, 2026  
**Current public release:** `0e164d28`  
**Earlier restore checkpoint:** `15fa86e6`  
**Immediate pre-adjustment restore checkpoint:** `cba7aa29`

## Owner request

The owner approved the broader Full Product Details readability direction and asked for **even larger section headings** plus **higher body-text contrast**. Before this second visual pass, the complete prior private state was saved as checkpoint `cba7aa29` so it can be restored independently of the earlier checkpoint `15fa86e6`.

## Private refinement

Every active Full Product Details heading now uses the same stronger Cormorant display role at **56 px on desktop** and **37.6 px on mobile**. The five-tab navigation remains Inter and preserves the approved two-column mobile layout, active-state underline, focus treatment, tab names, and content order.

Research Overview now uses white classification and lead text plus 90% white long-form body copy. Mechanism of Action and Applications use 92% white body text. Molecular Data uses brighter silver labels and 95% white values. Handling & Sources uses 92% white handling copy, 88% white documentation text, 90% white references, and an 84% white research-only notice. No wording, claims, product data, or research-only restrictions changed.

## Responsive evidence

The mutation-blocked browser audit covered all five tabs at 1440 px, 375 px, and 320 px for **15 total combinations**. Headings ranged from 37.6 px to 56 px, the targeted body and label roles met the 84% minimum opacity floor, all content retained Inter body typography, and no horizontal overflow occurred. Six non-read-only background requests were blocked by the audit harness, and no application mutation was permitted.

Representative visual evidence is stored outside the project at `/home/ubuntu/product-detail-contrast-private-ui/`. The reviewed images include desktop and mobile Research Overview, desktop Mechanism of Action and Molecular Data, and 320 px Applications and Handling & Sources. The editor-only cream Preview mode banner visible in screenshots is not part of the storefront.

## Validation

| Check | Result |
|---|---|
| TypeScript | Passed |
| Focused typography/mobile/theme tests | 34 passed |
| Complete credential-safe suite | 207 passed; 5 live/credential tests intentionally skipped |
| Production build | Passed; existing large-main-chunk advisory only |
| Responsive all-tab audit | 15/15 combinations passed |
| Horizontal overflow | None at 1440 px, 375 px, or 320 px |
| Integration status | Resend, ShipStation, and Whitcomb remain configured |
| Database invariants | 4 existing orders, 0 cancelled, 1 paid, 2 Whitcomb; counter remains `130002` so the next order remains `LAP-130003` |
| Runtime logs | No new error pattern |
| Diff integrity | Passed |

## Protected invariants

All 16 products, four signature blends, owner-confirmed prices including Retatrutide 30 mg at $200, all 16 COAs, research-only wording, descriptions, tabs, routes, cart, checkout, authentication, Admin, Whitcomb, Resend, ShipStation, five-minute Heartbeat, database records, order sequence, domains, and production checkpoint remain unchanged.

## Publication gate

The owner explicitly instructed: **“Approve and publish the changes to the section headings and body text contrast.”** Final publication and production verification are now authorized for this exact typography revision. Restore checkpoints `cba7aa29` and `15fa86e6` remain available.
